- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in allergan
Glenmark Stock Up After US Approval To Its Savella Generic
Shares of drug maker Glenmark Pharmaceuticals rose 0.52 per cent to Rs 868. 45 a unit on BSE on Friday, a day that saw the benchmark Sensex down by at least 50 points
Read More
Dr Reddy's To Buy Eight Products In US For $350 Million
The portfolio consists of products that are being divested by Teva as a precondition to its closing of the acquisition of Allergan's generics business, the Hyderabad-based firm said
Read More
Investors Stick With Pfizer CEO After Allergan Deal Collapse
In 2014, Pfizer failed in its unsolicited $118 billion bid to buy London-based drugmaker AstraZeneca Plc after that deal ran into staunch opposition from British politicians
Read More
Obama's Inversion Curbs Kill Pfizer's $160 Billion Allergan Deal
Pfizer will have to pay Allergan up to $400 million for its expenses as a result of terminating the deal, according to their merger agreement
Read More
Teva Set To Win EU Okay For $40.5 Billion Allergan Deal
Teva will gain bigger economies of scale, a crucial element in the low-margin generic drugs business, with the deal, the largest in Israel's corporate history.
Read More
Pfizer Set To Buy Allergan For $150 Billion To Create World's Biggest Drug Maker
The deal is sure to draw political ire in a US presidential election year because Pfizer would redomicile to Ireland, where Allergan is registered, in a so-called 'inversion' that would slash its corporate tax rate
Read More
Pfizer-Allergan Talks Accelerate Amid New Inversion Clamp-down
Pfizer is negotiating a price of $370 to $380 for each Allergan share. Allergan shares ended trading on Wednesday at $310.8 per share
Read More